The effect of Pentoxifylline and Tocotrienol in endometrial rejuvenation in the case of thin endometrium opting for frozen embryo transfer

Indira IVF Hospital Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•(a) History of one cancelled embryo transfer due to thin endo <7mm (after all conventional treatment as per institutional protocol.
•(b) Age 25–45 years,
•(c) Body mass index (BMI) 18.5 to 29.9 kg/m2
•(d) Recipients of Donor oocyte & Donor embryo.

•(a) Presence of uncontrolled endocrine disorders (uncontrolled diabetes mellitus/ hyperprolactinemia, thyroid dysfunction,
•(b) Previous major uterine surgery
•(c) Previous hysteroscopic surgery
•(d) Adenomyosis
•(e) Endometriosis
•(f) Untreated hydrosalpinx
•(h) Cotreatment with any Nitric Oxide donor
•(i) Patients with bleeding disorder or those who are at increased risk of retinal bleeding, peptic ulcer, or preoperative patients
•(j) Patients with Renal Impairment: Patients with creatinine clearance less than 30 mL/min
•(k) Allergy to xanthine derivatives, e.g., caffeine, theophylline, theobromine
•(l) Acute myocardial infarction or severe coronary disease due to increased risk of myocardial demand
•(m) Severe liver disease (Child pugh class C) or cirrhosis
•(n) Pregnancy and Breastfeeding
•(o) bleeding disorders (altered prothrombin time
•(p) Co-administration with
•(q) other antihypertensive drugs
•(r) Glibenclamide or metformin
•(s) other theophylline derivatives
•(t) Co- treatment with Aspirin

发起方

Indira IVF Hospital Private Limited